Cytoplasmic tail adaptors of Alzheimer's amyloid-β protein precursor

Molecular Neurobiology

Volumn 30, Issue 2, 2004, Pages 185-200

  Kawasumi, Masaoki ^a   Matsuda, Shuji ^a   Matsuoka, Masaaki ^a   Nishimoto, Ikuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

A PP(APP); Fe65; G protein; JIP; JIP1b IB1; mDab1; PID PTB; The GYENPTY motif; X11 Lin 10 Mint

Indexed keywords

ADAPTOR PROTEIN; AMYLOID PRECURSOR PROTEIN; C JUN N TERMINAL KINASE INTERACTING PROTEIN 1B; MOUSE DISABLED 1 PROTEIN; PROTEIN FE65; PROTEIN X 11; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN REGION; DNA POLYMORPHISM; ENZYME ACTIVITY; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CYTOPLASM; GENETICS; METABOLISM; MOLECULAR GENETICS;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CYTOPLASM; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 16644366941     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:30:2:185     Document Type: Review

References (121)

1. o. Nature 362, 75-79.
2. o heterotrimeric protein within a cell compartment specialized in signal transduction. J. Neurosci. 19, 1717-1727.
3. Chen W. J., Goldstein J. L., Brown M. S. (1990). NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265, 3116-3123.
4. Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10, 1084-1095.
5. Kavanaugh W. M., Williams L. T. (1994). An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266, 1862-1865.
6. Kavanaugh W. M., Turck C. W., Williams L. T. (1995). PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 268, 1177-1179.
7. Bork P., Margolis B. (1995). A phosphotyrosine interaction domain. Cell 80, 693-694.
8. Duilio A., Zambrano N., Mogavero A. R., Ammendola R., Cimino F., Russo T. (1991). A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucl. Acids Res. 19, 5269-5274.
9. Fiore F., Zambrano N., Minopoli G., Donini V., Duilio A., Russo T. (1995). The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein. J. Biol. Chem. 270, 30,853-30,856.
10. Guenette S. Y., Chen J., Jondro P. D., Tanzi R. E. (1996). Association of a novel human FE65-like protein with the cytoplasmic domain of the β-amyloid precursor protein. Proc. Natl. Acad. Sci. USA 93, 10,832-10,837.
11. Duilio A., Faraonio R., Minopoli G., Zambrano N., Russo T. (1998). Fe65L2: a new member of the Fe65 protein family interacting with the intracellular domain of the Alzheimer's β-amyloid precursor protein. Biochem. J. 330, 513-519.
12. Zambrano N., Buxbaum J. D., Minopoli G., et al. (1997). Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's β-amyloid precursor proteins. J. Biol. Chem. 272, 6399-6405.
13. Zambrano N., Minopoli G., de Candia P., Russo T. (1998). The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J. Biol. Chem. 273, 20,128-20,133.
14. Trommsdorff M., Borg J. P., Margolis B., Herz J. (1998). Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33,556-33,560.
15. Kinoshita A., Whelan C. M., Smith C. J., et al. (2001). Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. J. Neurosci. 21, 8354-8361.
16. Tanahashi H., Tabira T. (2002). Characterization of an amyloid precursor protein-binding protein Fe65L2 and its novel isoforms lacking phosphotyrosine-interaction domains. Biochem. J. 367, 687-695.
17. Chang Y., Tesco G., Jeong W. J., et al. (2003). Generation of the β-amyloid peptide and the amyloid precursor protein C-terminal fragment γ are potentiated by FE65L1. J. Biol. Chem. 278, 51,100-51,107.
18. Ermekova K. S., Zambrano N., Linn H., et al. (1997). The WW domain of neural protein FE65 interacts with proline-rich motifs in Mena, the mammalian homolog of Drosophila enabled. J. Biol. Chem. 272, 32,869-32,877.
19. Zambrano N., Bruni P., Minopoli G., et al. (2001). The β-amyloid precursor protein APP is tyrosine-phosphorylated in cells expressing a constitutively active form of the Abl protoncogene. J. Biol. Chem. 276, 19,787-19,792.
20. Sabo S. L., Ikin A. F., Buxbaum J. D., Greengard P. (2001). The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J. Cell. Biol. 153, 1403-1414.
21. Cao X., Sudhof T. C. (2001). A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120.
22. Minopoli G., de Candia P., Bonetti A., Faraonio R., Zambrano N., Russo T. (2001). The β-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. J. Biol. Chem. 276, 6545-6550.
23. Kinoshita A., Shah T., Tangredi M. M., Strickland D. K., Hyman B. T. (2003). The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J. Biol. Chem. 278, 41,182-41,188.
24. Kimberly W. T., Zheng J. B., Guenette S. Y., Selkoe D. J. (2001). The intracellular domain of the β-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J. Biol. Chem. 276, 40,288-40,292.
25. Kinoshita A., Whelan C. M., Smith C. J., Berezovska O., Hyman B. T. (2002). Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J. Neurochem. 82, 839-847.
26. Wang B., Hu Q., Hearn M. G., et al. (2004). Isoform-specific knockout of FE65 leads to impaired learning and memory. J. Neurosci. Res. 75, 12-24.
27. Borg J. P., Ooi J., Levy E., Margolis B. (1996). The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 6229-6241.
28. Tomita S., Ozaki T., Taru H., et al. (1999). Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J. Biol. Chem. 274, 2243-2254.
29. Tanahashi H., Tabira T. (1999). X11L2, a new member of the X11 protein family, interacts with Alzheimer's β-amyloid precursor protein. Biochem. Biophys. Res. Commun. 255, 663-667.
30. Zhang Z., Lee C. H., Mandiyan V., et al. (1997). Sequence-specific recognition of the internalization motif of the Alzheimer's amyloid precursor protein by the X11 PTB domain. EMBO J. 16, 6141-6150.
31. Okamoto M., Sudhof T. C. (1998). Mint 3: a ubiquitous mint isoform that does not bind to munc18-1 or -2. Eur. J. Cell. Biol. 77, 161-165.
32. Borg J. P., Lopez-Figueroa M. O., de Taddeo-Borg M., et al. (1999). Molecular analysis of the X11-mLin-2/CASK complex in brain. J. Neurosci. 19, 1307-1316.
33. Okamoto M., Sudhof T. C. (1997). Mints, Munc18-interacting proteins in synaptic vesicle exocytosis. J. Biol. Chem. 272, 31,459-31,464.
34. Kim S. K., Horvitz H. R. (1990). The Caenorhabditis elegans gene lin-10 is broadly expressed while required specifically for the determination of vulval cell fates. Genes Dev. 4, 357-371.
35. Duclos F., Boschert U., Sirugo G., Mandel J. L., Hen R., Koenig M. (1993). Gene in the region of the Friedreich ataxia locus encodes a putative transmembrane protein expressed in the nervous system. Proc. Natl. Acad. Sci. USA 90, 109-113.
36. Rodius F., Duclos F., Wrogemann K., et al. (1994). Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval. Am. J. Hum. Genet. 54, 1050-1059.
37. Simske J. S., Kaech S. M., Harp S. A., Kim S. K. (1996). LET-23 receptor localization by the cell junction protein LIN-7 during C. elegans vulval induction. Cell 85, 195-204.
38. Kaech S. M., Whitfield C. W., Kim S. K. (1998). The LIN-2/LIN-7/LIN-10 complex mediates basolateral membrane localization of the C. elegans EGF receptor LET-23 in vulval epithelial cells. Cell 94, 761-771.
39. Rongo C., Whitfield C. W., Rodal A., Kim S. K., Kaplan J. M. (1998). LIN-10 is a shared component of the polarized protein localization pathways in neurons and epithelia. Cell 94, 751-759.
40. Borg J. P., Straight S. W., Kaech S. M., et al. (1998). Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting. J. Biol. Chem. 273, 31,633-31,636.
41. Butz S., Okamoto M., Sudhof T. C. (1998). A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell 94, 773-782.
42. Borg J. P., Yang Y., De Taddeo-Borg M., Margolis B., Turner R. S. (1998). The X11α protein slows cellular amyloid precursor protein processing and reduces Aβ40 and Aβ42 secretion. J. Biol. Chem. 273, 14,761-14,766.
43. Sastre M., Turner R. S., Levy E. (1998). X11 interaction with β-amyloid precursor protein modulates its cellular stabilization and reduces amyloid β-protein secretion. J. Biol. Chem. 273, 22,351-22,357.
44. Ho C. S., Marinescu V., Steinhilb M. L., Gaut J. R., Turner R. S., Stuenkel E. L. (2002). Synergistic effects of Munc18a and X11 proteins on amyloid precursor protein metabolism. J. Biol. Chem. 277, 27,021-27,028.
45. Mueller H. T., Borg J. P., Margolis B., Turner R. S. (2000). Modulation of amyloid precursor protein metabolism by X11α/Mint-1. A deletion analysis of protein-protein interaction domains. J. Biol. Chem. 275, 39,302-39,306.
46. Tomita S., Fujita T., Kirino Y., Suzuki T. (2000). PDZ domain-dependent suppression of NF-κB/p65-induced Aβ42 production by a neuron-specific X11-like protein. J. Biol. Chem. 275, 13,056-13,060.
47. Biederer T., Cao X., Sudhof T. C., Liu X. (2002). Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms. J. Neurosci. 22, 7340-7351.
48. Lau K. F., McLoughlin D. M., Standen C. L., Irving N. G., Miller C. C. (2000). Fe65 and X11β co-localize with and compete for binding to the amyloid precursor protein. Neuroreport 11, 3607-3610.
49. Howell B. W., Lanier L. M., Frank R., Gertler F. B., Cooper J. A. (1999). The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell. Biol. 19, 5179-5188.
50. Homayouni R., Rice D. S., Sheldon M., Curran T. (1999). Disabled-1 binds to the cytoplasmic domain of amyloid precursor-like protein 1. J. Neurosci. 19, 7507-7515.
51. Gertler F. B., Bennett R. L., Clark M. J., Hoffmann F. M. (1989). Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58, 103-113.
52. Howell B. W., Gertler F. B., Cooper J. A. (1997). Mouse disabled (mDab1): a Src binding protein implicated in neuronal development. EMBO J. 16, 121-132.
53. Howell B. W., Hawkes R., Soriano P., Cooper J. A. (1997). Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389, 733-737.
54. D'Arcangelo G., Miao G. G., Chen S. C., Soares H. D., Morgan J. I., Curran T. (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719-723.
55. Sheldon M., Rice D. S., D'Arcangelo G., et al. (1997). Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice. Nature 389, 730-733.
56. Rice D. S., Sheldon M., D'Arcangelo G., Nakajima K., Goldowitz D., Curran T. (1998). Disabled-1 acts downstream of Reelin in a signaling pathway that controls laminar organization in the mammalian brain. Development 125, 3719-3729.
57. Trommsdorff M., Gotthardt M., Hiesberger T., et al. (1999). Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689-701.
58. Hiesberger T., Trommsdorff M., Howell B. W., et al. (1999). Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481-489.
59. D'Arcangelo G., Homayouni R., Keshvara L., Rice D. S., Sheldon M., Curran T. (1999). Reelin is a ligand for lipoprotein receptors. Neuron 24, 471-479.
60. Senzaki K., Ogawa M., Yagi T. (1999). Proteins of the CNR family are multiple receptors for Reelin. Cell 99, 635-647.
61. Dulabon L., Olson E. C., Taglienti M. G., et al. (2000). Reelin binds α3β1 integrin and inhibits neuronal migration. Neuron 27, 33-44.
62. Heber S., Herms J., Gajic V., et al. (2000). Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J. Neurosci. 20, 7951-7963.
63. Matsuda S., Yasukawa T., Homma Y., et al. (2001). c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. J. Neurosci. 21, 6597-6607.
64. Scheinfeld M. H., Roncarati R., Vito P., Lopez P. A., Abdallah M., D'Adamio L. (2002). Jun N-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's β-amyloid precursor protein (APP). J. Biol. Chem. 277, 3767-3775.
65. Yasuda J., Whitmarsh A. J., Cavanagh J., Sharma M., Davis R. J. (1999). The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell. Biol. 19, 7245-7254.
66. Kelkar N., Gupta S., Dickens M., Davis R. J. (2000). Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol. Cell. Biol. 20, 1030-1043.
67. Meyer D., Liu A., Margolis B. (1999). Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190 rhoGEF and its localization in differentiated neurons. J. Biol. Chem. 274, 35,113-35,118.
68. Stockinger W., Brandes C., Fasching D., et al. (2000). The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J. Biol. Chem. 275, 25,625-25,632.
69. Gotthardt M., Trommsdorff M., Nevitt M. F., et al. (2000). Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 275, 25,616-25,624.
70. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
71. Kuan C. Y., Yang D. D., Samanta Roy D. R., Davis R. J., Rakic P., Flavell R. A. (1999). The JNK1 and JNK2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676.
72. Yang D. D., Kuan C. Y., Whitmarsh A. J., et al. (1997). Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870.
73. Dickens M., Rogers J. S., Cavanagh J., et al. (1997). A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277, 693-696.
74. Whitmarsh A. J., Cavanagh J., Tournier C., Yasuda J., Davis R. J. (1998). A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281, 1671-1674.
75. Davis R. J. (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
76. Whitmarsh A. J., Davis R. J. (1998). Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem. Sci. 23, 481-485.
77. Kim I. J., Lee K. W., Park B. Y., et al. (1999). Molecular cloning of multiple splicing variants of JIP-1 preferentially expressed in brain. J. Neurochem. 72, 1335-1343.
78. Bonny C., Nicod P., Waeber G. (1998). IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J. Biol. Chem. 273, 1843-1846.
79. Mooser V., Maillard A., Bonny C., et al. (1999). Genomic organization, fine-mapping, and expression of the human islet-brain 1 (IB1)/c-Jun-amino- terminal kinase interacting protein-1 (JIP-1) gene. Genomics 55, 202-208.
80. Pellet J. B., Haefliger J. A., Staple J. K., et al. (2000). Spatial, temporal and subcellular localization of islet-brain 1 (IB1), a homologue of JIP-1, in mouse brain. Eur. J. Neurosci. 12, 621-632.
81. Thompson N. A., Haefliger J. A., Senn A., et al. (2001). Islet-brain1/JNK-interacting protein-1 is required for early embryogenesis in mice. J. Biol. Chem. 276, 27,745-27,748.
82. Whitmarsh A. J., Kuan C. Y., Kennedy N. J., et al. (2001). Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes Dev. 15, 2421-2432.
83. Bowman A. B., Kamal A., Ritchings B. W., et al. (2000). Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. Cell 103, 583-594.
84. Byrd D. T., Kawasaki M., Walcoff M., Hisamoto N., Matsumoto K., Jin Y (2001). UNC-16, a JNK-signaling scaffold protein, regulates vesicle transport in C. elegans. Neuron 32, 787-800.
85. Verhey K. J., Meyer D., Deehan R., et al. (2001). Cargo of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J. Cell. Biol. 152, 959-970.
86. Gunawardena S., Goldstein L. S. (2001). Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389-401.
87. Kamal A., Stokin G. B., Yang Z., Xia C. H., Goldstein L. S. (2000). Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28, 449-459.
88. Kamal A., Almenar-Queralt A., LeBlanc J. F., Roberts E. A., Goldstein L. S. (2001). Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP. Nature 414, 643-648.
89. Matsuda S., Matsuda Y., D'Adamio L. (2003). Amyloid β protein precursor (AβPP), but not AβPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J. Biol. Chem. 278, 38,601-38,606.
90. Rohn T. T., Ivins K. J., Bahr B. A., Cotman C. W., Cribbs D. H. (2000). A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis. J. Neurochem. 74, 2331-2342.
91. Sudo H., Jiang H., Yasukawa T., et al. (2000). Antibody-regulated neurotoxic function of cell surface β-amyloid precursor protein. Mol. Cell. Neurosci. 16, 708-723.
92. Mbebi C., See V., Mercken L., Pradier L., Muller U., Loeffler J. P. (2002). Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway. J. Biol. Chem. 277, 20,979-20,990.
93. Sudo H., Hashimoto Y., Niikura T., et al. (2001). Secreted Aβ does not mediate neurotoxicity by antibody-stimulated amyloid precursor protein. Biochem. Biophys. Res. Commun. 282, 548-556.
94. Hashimoto Y., Tsuji O., Niikura T., et al. (2003). Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. J. Neurochem. 84, 864-877.
95. 2-terminal kinase-mediated neurotoxic signal via dimerization. J. Pharmacol. Exp. Ther. 306, 889-902.
96. Scheinfeld M. H., Ghersi E., Davies P., D'Adamio L. (2003). Amyloid β protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1. J. Biol. Chem. 278, 42,058-42,063.
97. Taru H., Kirino Y., Suzuki T. (2002). Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J. Biol. Chem. 277, 27,567-27,574.
98. Scheinfeld M. H., Matsuda S., D'Adamio L. (2003). JNK-interacting protein-1 promotes transcription of Aβ protein precursor but not Aβ precursor-like proteins, mechanistically different than Fe65. Proc. Natl. Acad. Sci. USA 100, 1729-1734.
99. Tarr P. E., Roncarati R., Pelicci G., Pelicci P. G., D'Adamio L. (2002). Tyrosine phosphorylation of the β-amyloid precursor protein cytoplasmic tail promotes interaction with Shc. J. Biol. Chem. 277, 16,798-16,804.
100. Ando K., Iijima K. I., Elliott J. I., Kirino Y., Suzuki T. (2001). Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of β-amyloid. J. Biol. Chem. 276, 40,353-40,361.
101. Kesavapany S., Banner S. J., Lau K. F., et al. (2002). Expression of the Fe65 adapter protein in adult and developing mouse brain. Neuroscience 115, 951-960.
102. Sabo S. L., Lanier L. M., Ikin A. F., et al. (1999). Regulation of β-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J. Biol. Chem. 274, 7952-7957.
103. Hu Q., Jin L. W., Starbuck M. Y., Martin G. M. (2000). Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions. J. Neurosci. Res. 60, 73-86.
104. Delatour B., Mercken L., El Hachimi K. H., Colle M. A., Pradier L., Duyckaerts C. (2001). FE65 in Alzheimer's disease: neuronal distribution and association with neurofibrillary tangles. Am. J. Pathol. 158, 1585-1591.
105. Hu Q., Kukull W. A., Bressler S. L., et al. (1998). The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Hum. Genet. 103, 295-303.
106. Hu Q., Cool B. H., Wang B., Hearn M. G., Martin G. M. (2002). A candidate molecular mechanism for the association of an intronic polymorphism of FE65 with resistance to very late onset dementia of the Alzheimer type. Hum. Mol. Genet. 11, 465-475.
107. Lambert J. C., Mann D., Goumidi L., et al. (2000). A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Aβ loading in brains. Neurosci. Lett. 293, 29-32.
108. Guenette S. Y., Bertram L., Crystal A., et al. (2000). Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients. Neurosci. Lett. 296, 17-20.
109. Cousin E., Mannequin D., Ricard S., et al. (2003). A risk for early-onset Alzheimer's disease associated with the APBB1 gene (FE65) intron 13 polymorphism. Neurosci. Lett. 342, 5-8.
110. McLoughlin D. M., Irving N. G., Brownlees J., Brion J. P., Leroy K., Miller C. C. (1999). Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease. Eur. J. Neurosci. 11, 1988-1994.
111. Brich J., Shie F. S., Howell B. W., et al. (2003). Genetic modulation of tau phosphorylation in the mouse. J. Neurosci. 23, 187-192.
112. Mudher A., Chapman S., Richardson J., et al. (2001). Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase. J. Neurosci. 21, 4987-4995.
113. Schubert D., Cole G., Saitoh T., Oltersdorf T. (1989). Amyloid β protein precursor is a mitogen. Biochem. Biophys. Res. Commun. 162, 83-88.
114. Milward E. A., Papadopoulos R., Fuller S. J., et al. (1992). The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9, 129-137.
115. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-414.
116. Small D. H., Nurcombe V., Reed G., et al. (1994). A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J. Neurosci. 14, 2117-2127.
117. Zhu X., Raina A. K., Rottkamp C. A., Aliev G., Perry G., Boux H., Smith M. A. (2001). Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435-441.
118. Savage M. J., Lin Y. G., Ciallella J. R., Flood D. G., Scott R. W. (2002). Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J. Neurosci. 22, 3376-3385.
119. Setou M., Nakagawa T., Seog D. H., Hirokawa N. (2000). Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 288, 1796-1802.
120. Biederer T., Sudhof T. C. (2000). Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J. Biol. Chem. 275, 39,803-39,806.
121. Cohen A. R., Woods D. F., Marfatia S. M., et al. (1998). Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J. Cell. Biol. 142, 129-138.